News

Read the latest news from Health.

Filter results

You can narrow down the results using the filters

Audience

Topics

Our work

Year

2 results
  • Soliris® (eculizumab) available on PBS from 1 March 2022

    The program that subsidises Soliris® for patients with a rare condition called paroxysmal nocturnal haemoglobinuria (PNH) is changing. Until now, we have subsidised Soliris® under the Life Saving Drugs Program. From 1 March 2022, this will change to the Pharmaceutical Benefits Scheme (PBS).
  • Driving social inclusion through sport and physical activity

    A new initiative will help migrant groups, people with physical and intellectual disabilities and Aboriginal and Torres Strait Islander peoples to participate in sport and physical activity.